首页> 外国专利> Methods of Treating Disorders Related to Protease-activated Receptors-induced Cell activation

Methods of Treating Disorders Related to Protease-activated Receptors-induced Cell activation

机译:治疗与蛋白酶激活受体诱导的细胞活化有关的疾病的方法

摘要

PURPOSE: Provided is a method of treating disorders related to protease-activated receptors(PARs)-induced cell activation, such as thrombin-inducing platelet aggregation, effectively. CONSTITUTION: The method for treating disorders related to protease-activator receptor(PARs)-induced cell activation is characterized by administrating an effective amount of a compound represented by formula(1) into non-human mammals. In the formula(1), Ar1, Ar2 and Ar3 are independently phenyl, thienyl, furyl or pyrrolyl; R1, R2, R3, R4, R5 and R6 are independently H, halogen, -OR, -OH, -SR, -SH, -R, -C(=O)OH, -C(=O)OR, -C(=O)SH, -C(=O)SR, -C(=O)NRR', -ROH, -ROR', -RSR', -RSH, -NRR', -NHR, -NH2, -RNR'R", -RNH2, -RNHR' or -RSR' or, R1 and R2, R3 and R4, R5 and R6 are -ORO- together(wherein R, R' and R" are independently C1-4 alkyl); and n is an integer of 1, 2 or 3.
机译:目的:提供一种有效治疗与蛋白酶激活受体(PARs)诱导的细胞活化有关的疾病的方法,例如凝血酶诱导的血小板聚集。组成:治疗与蛋白酶激活剂受体(PARs)诱导的细胞活化有关的疾病的方法,其特征在于将有效量的式(1)表示的化合物施用于非人类哺乳动物。在式(1)中,Ar 1,Ar 2和Ar 3独立地为苯基,噻吩基,呋喃基或吡咯基; R1,R2,R3,R4,R5和R6独立为H,卤素,-OR,-OH,-SR,-SH,-R,-C(= O)OH,-C(= O)OR,-C (= O)SH,-C(= O)SR,-C(= O)NRR',-ROH,-ROR',-RSR',-RSH,-NRR',-NHR,-NH2,-RNR' R”,-RNH2,-RNHR'或-RSR'或R1和R2,R3和R4,R5和R6一起为-ORO-(其中R,R'和R”独立地为C1-4烷基); n是1、2或3的整数。

著录项

  • 公开/公告号KR100801587B1

    专利类型

  • 公开/公告日2008-02-05

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20010036054

  • 发明设计人 쿠오셩츄;리팡유;텅쳐밍;

    申请日2001-06-23

  • 分类号A61K31/4162;

  • 国家 KR

  • 入库时间 2022-08-21 19:52:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号